146 related articles for article (PubMed ID: 30600292)
41. Muscle ammonia and glutamine exchange during chronic liver insufficiency in the rat.
Dejong CH; Deutz NE; Soeters PB
J Hepatol; 1994 Sep; 21(3):299-307. PubMed ID: 7836697
[TBL] [Abstract][Full Text] [Related]
42. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
43. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension.
Jalan R; De Chiara F; Balasubramaniyan V; Andreola F; Khetan V; Malago M; Pinzani M; Mookerjee RP; Rombouts K
J Hepatol; 2016 Apr; 64(4):823-33. PubMed ID: 26654994
[TBL] [Abstract][Full Text] [Related]
44. Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation.
Leke R; Oliveira DL; Forgiarini LF; Escobar TD; Hammes TO; Meyer FS; Keiding S; Silveira TR; Schousboe A
Metab Brain Dis; 2013 Jun; 28(2):187-92. PubMed ID: 23111918
[TBL] [Abstract][Full Text] [Related]
45. Possible implication of ciliary neurotrophic factor (CNTF) and beta-synuclein in the ammonia effect on cultured rat astroglial cells: a study using DNA and protein microarrays.
Bodega G; Suárez I; López-Fernández LA; Almonacid L; Zaballos A; Fernández B
Neurochem Int; 2006 Jun; 48(8):729-38. PubMed ID: 16483693
[TBL] [Abstract][Full Text] [Related]
46. Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema.
Miquel M; Bartolí R; Odena G; Serafín A; Cabré E; Galan A; Barba I; Córdoba J; Planas R
Liver Int; 2010 Aug; 30(7):979-87. PubMed ID: 20492509
[TBL] [Abstract][Full Text] [Related]
47. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
Lu L; Wu C; Lu BJ; Xie D; Wang Z; Bahaji Azami NL; An YT; Wang HJ; Ye G; Sun MY
J Ethnopharmacol; 2020 Mar; 249():112301. PubMed ID: 31622746
[TBL] [Abstract][Full Text] [Related]
48. Gut ammonia production and its modulation.
Romero-Gómez M; Jover M; Galán JJ; Ruiz A
Metab Brain Dis; 2009 Mar; 24(1):147-57. PubMed ID: 19067141
[TBL] [Abstract][Full Text] [Related]
49. O-GlcNAcylation-dependent upregulation of HO1 triggers ammonia-induced oxidative stress and senescence in hepatic encephalopathy.
Görg B; Karababa A; Schütz E; Paluschinski M; Schrimpf A; Shafigullina A; Castoldi M; Bidmon HJ; Häussinger D
J Hepatol; 2019 Nov; 71(5):930-941. PubMed ID: 31279900
[TBL] [Abstract][Full Text] [Related]
50. Portacaval anastomosis-induced hyperammonemia does not lead to oxidative stress.
Yang X; Bosoi CR; Jiang W; Tremblay M; Rose CF
Metab Brain Dis; 2010 Mar; 25(1):11-5. PubMed ID: 20195725
[TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo Evaluation of Succinic Acid-Substituted Mesoporous Silica for Ammonia Adsorption: Potential Application in the Management of Hepatic Encephalopathy.
Mohammadi H; Heidari R; Niknezhad SV; Jamshidzadeh A; Farjadian F
Int J Nanomedicine; 2020; 15():10085-10098. PubMed ID: 33363368
[TBL] [Abstract][Full Text] [Related]
52. Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia.
Jamshidzadeh A; Heidari R; Abasvali M; Zarei M; Ommati MM; Abdoli N; Khodaei F; Yeganeh Y; Jafari F; Zarei A; Latifpour Z; Mardani E; Azarpira N; Asadi B; Najibi A
Biomed Pharmacother; 2017 Feb; 86():514-520. PubMed ID: 28024286
[TBL] [Abstract][Full Text] [Related]
53. A new experimental model for acute hepatic failure in rats.
Teixeira AR; Machado MC; Kubrusly MS; Molan NT; Bellodi-Privato M; Leite KR; D'Albuquerque LA
Acta Cir Bras; 2010 Jun; 25(3):269-74. PubMed ID: 20498940
[TBL] [Abstract][Full Text] [Related]
54. Umbelliferone prevents oxidative stress, inflammation and hematological alterations, and modulates glutamate-nitric oxide-cGMP signaling in hyperammonemic rats.
Germoush MO; Othman SI; Al-Qaraawi MA; Al-Harbi HM; Hussein OE; Al-Basher G; Alotaibi MF; Elgebaly HA; Sandhu MA; Allam AA; Mahmoud AM
Biomed Pharmacother; 2018 Jun; 102():392-402. PubMed ID: 29573618
[TBL] [Abstract][Full Text] [Related]
55. Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.
Hertz L; Song D; Peng L; Chen Y
Neurochem Res; 2017 Mar; 42(3):721-736. PubMed ID: 27286679
[TBL] [Abstract][Full Text] [Related]
56. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
[TBL] [Abstract][Full Text] [Related]
57. [Prevention and treatment of hepatic encephalopathy].
Sivolap YP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
Blanco Vela CI; Poo Ramírez JL
Ann Hepatol; 2011 Jun; 10 Suppl 2():S55-9. PubMed ID: 22228883
[TBL] [Abstract][Full Text] [Related]
59. Taurine transporter (TauT) deficiency impairs ammonia detoxification in mouse liver.
Qvartskhava N; Jin CJ; Buschmann T; Albrecht U; Bode JG; Monhasery N; Oenarto J; Bidmon HJ; Görg B; Häussinger D
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6313-6318. PubMed ID: 30862735
[TBL] [Abstract][Full Text] [Related]
60. Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: Reversed by anti-TNF-α treatment.
Balzano T; Dadsetan S; Forteza J; Cabrera-Pastor A; Taoro-Gonzalez L; Malaguarnera M; Gil-Perotin S; Cubas-Nuñez L; Casanova B; Castro-Quintas A; Ponce-Mora A; Arenas YM; Leone P; Erceg S; Llansola M; Felipo V
J Hepatol; 2020 Sep; 73(3):582-592. PubMed ID: 30654069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
